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Immunity
Previewscontinue to explore macrophage popu-
lation dynamics in other unchartered
tissues.
REFERENCES
Epelman, S., Lavine, K.J., Beaudin, A.E., Sojka,
D.K., Carrero, J.A., Calderon, B., Brija, T., Gautier,
E.L., Ivanov, S., Satpathy, A.T., et al. (2014).
Immunity 40, this issue, 91–104.
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S.,
See, P., Gokhan, S., Mehler, M.F., Conway, S.J.,
Ng, L.G., Stanley, E.R., et al. (2010). Science 330,
841–845.Hashimoto, D., Chow, A., Noizat, C., Teo, P.,
Beasley, M.B., Leboeuf, M., Becker, C.D., See,
P., Price, J., Lucas, D., et al. (2013). Immunity 38,
792–804.
Hume, D.A., Perry, V.H., and Gordon, S. (1984).
Anat. Rec. 210, 503–512.
Jenkins, S.J., Ruckerl, D., Cook, P.C., Jones, L.H.,
Finkelman, F.D., van Rooijen, N., MacDonald,
A.S., and Allen, J.E. (2011). Science 332, 1284–
1288.
Klein, I., Cornejo, J.C., Polakos, N.K., John, B.,
Wuensch, S.A., Topham, D.J., Pierce, R.H., and
Crispe, I.N. (2007). Blood 110, 4077–4085.ImmunitySchulz, C., Gomez Perdiguero, E., Chorro, L.,
Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz,
M., Wu, B., Jacobsen, S.E., Pollard, J.W., et al.
(2012). Science 336, 86–90.
Wynn, T.A., Chawla, A., and Pollard, J.W. (2013).
Nature 496, 445–455.
Yona, S., Kim, K.W., Wolf, Y., Mildner, A., Varol, D.,
Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams,
M., Misharin, A., et al. (2013). Immunity 38, 79–91.
Zigmond, E., Varol, C., Farache, J., Elmaliah, E.,
Satpathy, A.T., Friedlander, G., Mack, M., Shpigel,
N., Boneca, I.G., Murphy, K.M., et al. (2012).
Immunity 37, 1076–1090.Professional Differences
in Antigen Presentation to iNKT CellsGennaro De Libero1,* and Lucia Mori1
1Experimental Immunology, Department of Biomedicine, University Hospital Basel, Basel, Switzerland and Singapore Immunology Network
(SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore
*Correspondence: gennaro_delibero@immunol.a-star.edu.sg
http://dx.doi.org/10.1016/j.immuni.2013.12.008
Invariant natural killer T cells are preactivated lymphocytes that react upon recognition of CD1d-antigen
complexes. Accordingly, any type of CD1d-positive cell could behave as antigen-presenting cell (APC).
In this issue of Immunity, Arora et al. (2014), report that professional APCs still make the difference.A mechanistic approach to antigen pre-
sentation has to consider individual
steps involved in final T cell stimulation.
Accordingly, different actors contribute
to antigen presentation, namely the
antigen-presenting cell (APC), the antigen
itself, and the responding T cell. Many
studies have defined the features that
provide superior competence of an APC;
thereby cells possessing these functions
are usually defined as ‘‘professional’’
APCs. Because T cells may recognize
proteins, lipids, and small metabolites as
antigens, professional APCs may deal
with chemically different antigens and
the talent possessed by APCs may be
different according to the type of pre-
sented antigen.
Presentation of lipid antigens is influ-
enced by the capacity to internalize and
bring lipids within the endosomal com-
partments where they encounter CD1
antigen-presenting molecules; to digest
lipids, if necessary, thus generating
smaller molecules that become morepalatable to efficient binding to CD1 mol-
ecules. The way of recycling of CD1-lipid
complexes defines the plasmamembrane
display of the complexes formed within
the APC, their pace of internalization
and lysosomal degradation. These latter
parameters directly impact antigen avail-
ability to T cell recognition. An important
issue, which remains poorly investigated,
is the display of the complexes within
defined plasma membrane domains. The
assembly of the CD1-lipid complexes
within membrane rafts, in packed do-
mains, or their dispersed distribution
ultimately affect the efficacy of antigen
recognition (Im et al., 2009). Two addi-
tional features deeply influencing T cell
responses are the availability on APCs
of costimulatory molecules interacting
with respective partner receptors dis-
played on T cells and the amounts of
CD1-presenting molecules expressed on
the surface of APC. Despite intense
efforts, we still do not know whether
unique costimulatory molecules areinvolved in lipid antigen presentation,
and we are slowly starting to comprehend
the mechanisms that control CD1 expres-
sion at epigenetic, transcriptional, and
posttranslational levels.
The second important actor of lipid
antigen presentation is the lipid antigen.
The lipid structure must obviously be
compatible with binding to CD1 mole-
cules. In some instances, an accurate
series of trimmings, which utilize a
variety of hydrolases, and probably also li-
pases, are required. The structures of lipid
antigens dictate their availability within
the extracellular environment and their
distribution to membranes of different
endosomal compartments. How lipid
antigens are extracted from membranes
and escorted until their insertion within
CD1 molecules also depends on lipid
structure. Lipid-binding proteins and
chaperones are important and their
redundancy remains unexplored.
The third actor is the T cell. T lympho-
cytes may directly influence the functions40, January 16, 2014 ª2014 Elsevier Inc. 5
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Previewsof APCs. Upon activation, T cells may
impact APC maturation and their expres-
sion of surface molecules. An important
final outcome of this mutual inspiration
is generation of mature APCs differing
in their presentation capacity. Given all
these intertwined mechanisms contrib-
uting to lipid antigen presentation, one
main question is which cell optimally
presents lipid antigens in vivo and how
do APCs affect the quality of lipid-specific
T cell responses?
The study by Arora et al. (2014) in the
present issue of Immunity shows that
a single subset of dendritic cells (DCs),
namely CD8a+ DEC205-positive DCs
(CD8a+ DCs) efficiently internalize exo-
genous lipid antigens, accumulate
stimulatory CD1d-loaded molecules, and
induce robust invariant natural killer
T (iNKT) cell responses. The importance
of CD8a+ DC is supported by experiments
performed in Batf3-deficient mice, in
which this DC population is impaired.
Although these mice have normal
numbers of functional iNKT cells, they
show inefficient iNKT responses to syn-
thetic analogs of a-galactosylceramide
(aGalCer) and to lipid antigens introduced
by infection with Streptococcus pneumo-
niae (which naturally expresses an iNKT-
activating lipid) or with Mycobacterium
bovis bacillus Calmette-Gue´rin (BCG)
modified by incorporation of synthetic
aGalCer analogs. Thus, CD8a+ DCs
have a key role in handling lipids delivered
in various ways.
The study of Arora et al. leaves open the
issue of the cellular qualities that make
this DC population so efficient. Future
investigations might address how CD8a+
DCs degrade lipid antigens, influencing
the display time of antigenic complexes
in vivo, their capacity of loading and
unloading CD1 molecules, and the mode
of CD1-lipid complexes assembly on
their plasma membrane. Finally, the type
of costimulatory molecules expressed
by CD8a+ DCs might also represent
a valid passport for their identification as
superior APC in vivo.
The Arora et al. study adds to a series
of published ones in which the same
crucial question was investigated with
multiple approaches, and that provided
a multifaceted picture.
A reduced stimulation of iNKT cells
has been observed in mice depleted
of Kupffer cells and macrophages and6 Immunity 40, January 16, 2014 ª2014 Elsevchallenged with a lipid antigen provided
in a particulate form such as bacteria
Borrelia burgdorferi (Lee et al., 2010),
Sphingomonas yanoikuyae, or coated
on silica particles (Barral et al., 2010).
Moreover, in vivo imaging has shown
iNKT cells preferentially crawling near
CD169+ macrophages, which also
proved more efficient than CD11c+ DC
and B cells in in vitro iNKT cell activation
(Barral et al., 2010). These studies
made a strong case for the in vivo
relevance of macrophages in inter-
nalizing and presenting particulate lipid
antigens.
B cells are the third type of CD1d-ex-
pressing cells that present lipid antigens.
B cells internalizing lipid antigens through
their B cell receptor activated iNKT cells,
thus receiving selective help (Barral
et al., 2008; King et al., 2012). Studies
elegantly performed with lineage-specific
deletion of the cd1d gene, suggest
that the mechanisms involved in antigen
presentation might be more complex
(Bai et al., 2012). Indeed, when lipid
antigens are injected in a soluble form
CD11c+ DC, monocytes and B cells are
all involved in lipid antigen presentation.
A polysaccharide administered with
liposomes containing aGalCer requires
the presence of CD1d-expressing B cells
for optimal iNKT cell response, B cell help,
and antibody production (Bai et al., 2013).
However, when the efficiency of B cell
lipid presentation is compared with
that of macrophages and DCs, B cells
always prove to be the less efficient
APCs (Arora et al., 2014; Bai et al., 2012;
Barral et al., 2010).
Which then is the cell type that presents
lipid antigens in vivo? The interpretations
of the experimental findings are only
in apparent contradiction. A unifying
explanation is that the formulation of the
lipid, and probably also its abundance,
determine which cell type efficiently
internalizes and presents lipid antigens
in vivo. However, if the attention of the
experimenter is focused on the functional
outcome of lipid antigen presentation,
several APCs become important. If acti-
vation of iNKT cells is the endpoint, it is
undisputed that DCs remain the winning
professional APCs. Instead, if microbial
clearance or antibody production are
the analyzed functions, macrophages
and B cells become main protagonists
as well.ier Inc.The study of Arora et al. addresses
a second important question, which has
implications for optimizing iNKT ligands
for translational research; i.e., how lipid
antigens differing in their lipid moieties
might induce opposite functional out-
comes. Injecting the C26:0 aGalCer
analog (containing a 26 carbon-long fatty
acid without unsaturated bonds) resulted
in a T helper 0 (Th0) cell-like response,
whereas a C20:2 analog (with a 20 car-
bon-long fatty acid and two unsaturated
bonds) predominantly induced a Th2
cell-like response. Moreover, a C-glyco-
side variant containing a nonhydrolysable
carbon linking the sugar to the ceramide
backbone induced strong Th1 cell-like
responses. The differential functional
outcome of these analogs, which share
identical sugar moieties, was ascribed to
a series of mechanisms identified and
recognized important at different times.
Initially it has been proposed that the
capacity to form more stable complexes
with CD1d is the discriminatory feature
(Miyamoto et al., 2001). Then, Th1 cell
bias was found with CD1d-lipid com-
plexes preferentially stockpiling in lipid
rafts and occurring with more hydropho-
bic analogs, loaded intracellularly and
following CD1d recycling pathways.
Instead, less hydrophobic analogs loaded
onto CD1d on the plasma membrane
result in a dispersed membrane distribu-
tion of the antigen complexes (Im et al.,
2009). Lineage-specific deletion of the
cd1d gene suggests that while Th1
cell-biasing lipids are preferentially pre-
sented by DC and monocytes, Th2 cell-
biasing compounds are also presented
by B cells, which notoriously are deficient
in secreting Th1 cell-inducing cytokines
(Bai et al., 2012).
The study of Arora et al. adds another
mechanism that relies on the selective
upregulation of distinctive accessory
molecules on APCs, as a response to
different aGalCer analogs. The costimula-
tory CD70, Rae-1, and CD86 molecules
were upregulated after injection of Th1
cell-inducing analogs,whereas the coinhi-
bitory PD-L1 and PD-L2were upregulated
after Th2 cell-inducing ones. Surface
modulation of thesemolecules was prom-
inently induced on CD8a+ DCs and was
dependent on CD1d expression by
APCs and iNKT presence, suggesting a
close interaction between APCs and re-
sponding iNKT cells. These findings also
Figure 1. Instruction of CD8a+ DCs by iNKT Cells
Lipid antigens inducing a Th1 or Th0 cell-like response (aGalCer C26:0 and C-glycoside) stimulate iNKT
cells to release IFN-g. iNKT cells also promote on CD8a+ DC upregulation of the costimulatory molecules
CD40, CD80, CD70, Rae1, and CD86. These molecules positively influence iNKT cell response and also
participate in bystander activation of NK cells, which in turn release IFN-g and contribute to the Th1 cell-
like response to lipid antigens. Instead, Th2 cell-inducing lipids (aGalCer C20:2) activate iNKT cells to
release low amounts of IFN-g. In addition, iNKT cells responding to these lipid antigens instruct CD8a+
DCs to upregulate surface expression of PD-L1 and PD-L2 coinhibitory molecules. These molecules
engage PD-1 on bystander NK cells and negatively control their response, thus contributing to a skewed
Th2 cell-like response to those lipid antigens.
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Previewsindicate that the same population of
CD8a+ DCs behaves as professional
APCs leading to Th1 or Th2 cell-like
biased responses. Differential expression
of accessory molecules on APC did not
affect the amounts of interleukin-12 (IL-
12) nor IL-4 in serum, whereas it had
dramatic effects on the amounts of inter-
feron-g (IFN-g) released by NK cells
(Figure 1). Indeed, this cell population par-
ticipates in the Th1 cell-like response
upon aGalCer administration in vivo and
its cooptation is influenced by initial iNKTcell responses (Carnaud et al., 1999).
Resembling many unexpected discov-
eries, the findings of Arora et al. raise a
new series of questions, including the
mechanism of how iNKT cells regulate
the expression of accessory molecules
onCD8a+ DCs, which is themicroenviron-
ment influencing this cellular crosstalk,
and the engagement rules of NK cells
upon DC instruction by iNKT cells.
A great merit of Arora’s study is the
renewed indication that emergence of
the immune response is a multipartneredImmunityaffair. Thereby, in addition to the
mechanistic biochemical, biophysical,
and structural aspects of antigen
recognition, the importance of cellular
interactions and their mutual influence
must also be acknowledged. This com-
munity-based view should be recognized
to fully understand what makes a mole-
cule immunogenic in vivo. Therefore,
while the particular ‘‘profession’’ of an
APC contributes to the quality of the
immune response, other parameters as
outlined above influence its ‘‘professional
behavior.’’
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